Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.1.355

Aberrant DNA Methylation and Epigenetic Inactivation of hMSH2 Decrease Overall Survival of Acute Lymphoblastic Leukemia Patients via Modulating Cell Cycle and Apoptosis  

Wang, Cai-Xia (Department of Internal Medicine, Guangzhou First People's Hospital, Guangzhou Medical University)
Wang, Xiang (School of Public Health, Guangzhou Medical University)
Liu, Hai-Bai (School of Public Health, Guangzhou Medical University)
Zhou, Zhi-Heng (School of Public Health, Guangzhou Medical University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.1, 2014 , pp. 355-362 More about this Journal
Abstract
Objective: Altered regulation of many transcription factors has been shown to play important roles in the development of leukemia. hMSH2 can modulate the activity of some important transcription factors and is known to be a regulator of hematopoietic differentiation. Herein, we investigated epigenetic regulation of hMSH2 and its influence on cell growth and overall survival of acute lymphoblastic leukemia (ALL) patients. Methods: hMSH2 promoter methylation status was assessed by COBRA and pyrosequencing in 60 ALL patients and 30 healthy volunteers. mRNA and protein expression levels of hMSH2, PCNA, CyclinD1, Bcl-2 and Bax were determined by real time PCR and Western blotting, respectively. The influence of hMSH2 on cell proliferation and survival was assessed in transient and stable expression systems. Results: mRNA and protein expression of hMSH2 and Bcl-2 was decreased, and that of PCNA, CyclinD1 and Bax was increased in ALL patients as compared to healthy volunteers (P<0.05). hMSH2 was inactivated in ALL patients through promoter hypermethylation. Furthermore, hMSH2 hypermethylation was found in relapsed ALL patients (85.7% of all cases). The median survival of patients with hMSH2 methylation was shorter than that of patients without hMSH2 methylation (log-rank test, P=0.0035). Over-expression of hMSH2 in cell lines resulted in a significant reduction in growth and induction of apoptosis. Conclusions: This study suggests that aberrant DNA methylation and epigenetic inactivation of hMSH2 play an important role in the development of ALL through altering cell growth and survival.
Keywords
Acute lymphoblastic leukemia; hMSH2; DNA methylation; survival; cell apoptosis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Cameron ER, Neil JC (2004). The Runx genes: lineage-specific oncogenes and tumor suppressors. Oncogene, 23, 4308-14.   DOI   ScienceOn
2 Choi JH, Park SH, Park J, et al (2007). Site-specific methylation of CpG nucleotides in the hTERT promoter region can control the expression of hTERT during malignant progression of colorectal carcinoma. Biochem Biophys Res Commun, 361, 615-20.   DOI   ScienceOn
3 Costello JF, Plass C (2001). Methylation matters. J Med Genet, 38, 285-303.   DOI
4 Fiumicino S, Martinelli S, Colussi C, et al(2000). Sensitivity to DNA crosslinking chemotherapeutic agents inmismatch repair-defective cells in vitro and in xenografts. Int J Cancer, 85, 590-6.   DOI
5 Gaynon PS (2005). Childhood acute lymphoblastic leukaemia and relapse. Br J Haematol, 131, 579-87.   DOI   ScienceOn
6 Hewish M, Lord CJ, Martin SA, et al (2010). Mismatch repair deficient colorectal cancer in the era of personalized treatment. Nat Rev Clin Oncol, 7, 197-208.   DOI   ScienceOn
7 Kuang SQ, Tong WG, Yang H, et al (2008). Genomewide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia. Leukemia, 22, 1529-38.   DOI   ScienceOn
8 KyungHwa L, JiShin L, JongHee N, et al (2011). Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence. Langenbecks Arch Surg, 396, 1017-26.   DOI   ScienceOn
9 Caixia W, Ping M, Qinghua D, et al (2009). CpG island methylation of hMLH1 and hMSH2 gene and their expressions in acute leukemia patients. Chin J Public Health, 7, 870-2.
10 Blyth K, Slater N, Hanlon L, et al (2009). Runx1promotes B-cell survival and lymphoma development. Blood cells Mol Dis, 43, 12-9.   DOI   ScienceOn
11 Brooks KR, To K, Joshi MBM, et al (2003). Measurement of chemoresistance markers in patients with stage III non-small cell lung cancer: a novel approach for patient selection. Ann Thorac Surg, 76, 187-93.   DOI   ScienceOn
12 Calvisi, D F, Ladu S, Gorden A, et al (2007). Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J Clin Invest, 117, 2713-22.   DOI   ScienceOn
13 Shimizu K, Onishi M, Sugata E, et al (2007). Disturbance of DNA methylation patterns in the early phase of hepatocarcinogenesis induced by a cholinedeficient l-amino acid-defined diet in rats. Cancer Sci, 98, 1318-22.   DOI   ScienceOn
14 Yu X, Hong S, Faustman EM (2008). Cadmium-induced activation of stress signaling pathways, disruption of ubiquitin-dependent protein degradation and apoptosis in primary rat Sertoli cell-gonocyte cocultures. Toxicol Sci, 104, 385-96.
15 Zelent A, Greaves M, Enver T (2004). Role of the TEL-AML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia. Oncogene, 23, 4275-83.   DOI   ScienceOn
16 Zhiheng Z, Yixiong L, Caixia W (2012). Analysis of aberrant methylation in DNA repair genes during malignant transformation of human bronchial epithelial cells induced by cadmium. Toxicol Sci., 125, 412-7.   DOI   ScienceOn
17 Takeshi N, Jennifer R, Matthias K, et al (2010). Somatic Hypermethylation of MSH2 Is a Frequent Event in Lynch Syndrome Colorectal Cancers. Cancer Res, 70, 3098-108.   DOI   ScienceOn
18 Ribic CM, Sargent DJ, Moore MJ, et al (2003). Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med, 349, 247-57.   DOI   ScienceOn
19 Shaoqing K, Hao B, Zhihong F, et al (2010). Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia. Blood, 115, 2412-9.   DOI   ScienceOn
20 Slany RK (2005). When epigenetics kills: MLL fusion proteins in leukemia. Hematol Oncol, 23, 1-9.   DOI   ScienceOn
21 Ward RL, Cheong K, Ku SL, et al (2003). Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability. J Clin Oncol, 21, 3729-36.   DOI   ScienceOn
22 Yongzhong H, Fengqin G, Qinhong, et al (2007). Mechanisms of signal transduction: Bcl2 impedes DNA mismatch repair by directly regulating the hMSH2-hMSH6 heterodimeric complex. J Biol Chem, 282, 9279-87.   DOI   ScienceOn
23 Youn CK, Cho H, Kim S, et al (2005). Bcl-2 expression suppresses mismatch repair activity through inhibition of E2F transcriptional activity. Nat Cell Biol, 7, 137-47.   DOI   ScienceOn
24 Meyers M, Wagner MW, Hwang HS, et al (2001). Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidinemediated cell death and cell cycle responses. Cancer Res, 61, 5193-201.
25 Ligtenberg MJ, Kuiper RP, Chan TL, et al (2009). Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3-exons of TACSTD1. Nat Genet, 41, 112-7.   DOI   ScienceOn
26 Mrozek K, Heerema NA, Bloomfield CD (2004). Cytogenetics in acute leukemia. Blood Rev, 18, 115-36.   DOI   ScienceOn
27 Loo TW, Clarke DM (2005). Recentprogress in understanding themechanism of P-glycoprotein-mediated drug efflux. J Membrn Bio, 206, 173-85.   DOI   ScienceOn
28 Marsischky GT, Filosi N, Kane MF, et al (1996). Redundancy of Saccharomyces cerevisiae MSH3 and MSH6 in MSH2-dependent mismatch repair. Genes Dev, 10, 407-20.   DOI   ScienceOn
29 Meyers M, Wagner MW, Mazurek A, et al (2005). DNA mismatch repair-dependent response to fluoropyrimidinegenerated damage. J Biol Chem, 280, 5516-26.   DOI   ScienceOn
30 O'Neil J, Look AT (2007). Mechanisms of transcription factor deregulation in lymphoid cell transformation. Oncogene, 26, 6838-49.   DOI   ScienceOn
31 Plasschaert SL, Kamps WA, Vellenga E, et al (2004). Prognosis in childhood and adult acute lymphoblastic leukaemia: a question of maturation? Cancer Treat Rev, 30, 37-51.   DOI   ScienceOn
32 Pogribny P, James SJ (2002). De novo methylation of the p16INK4A gene in early preneoplastic liver and tumors induced by folate/methyl deficiency in rats. Cancer Lett, 187, 69-75.   DOI   ScienceOn
33 Pui CH, Carroll WL, Meshinchi S, et al (2011). Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol, 29, 551-65.   DOI   ScienceOn
34 Pui CH, Relling MV, Downing JR (2004). Acute lymphoblastic leukemia. N Engl J Med, 350, 1535-48.   DOI   ScienceOn
35 Deguchi M, Shiina H, Igawa M, et al (2003). DNA mismatch repair genes in renal cell carcinoma. J Urol, 169, 2365-71.   DOI   ScienceOn
36 Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP (1998). Alterations in DNA methylation: A fundamental aspect of neoplasia. Adv Cancer Res, 72, 141-96.
37 Xinarianos G, LiloglouT, PrimeW, et al (2000). hMLH1and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas. Cancer Res, 60, 4216-21.
38 Fishel R (2001). The selection for mismatch repair defects in hereditary nonpolyposis colorectal cancer: Revising the mutator hypothesis. Cancer Res, 61, 7369-74.